3 studies found for:    15800326 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer
Condition: Metastatic Cancer
Interventions: Biological: PG13-CEA_TCR (Anti-CEA TCR PBL);   Drug: Aldesleukin
2 Terminated
Has Results
Drosophila-generated CTL
Condition: Metastatic Cutaneous Melanoma
Interventions: Drug: fludarabine;   Drug: cyclophosphamide;   Drug: Drosophila-peptide pulsed Melanoma-reactive autologous CD8+ PBL;   Drug: Aldesleukin
3 Recruiting Phase I Study of B Cell Malignancies Using T Cells Expressing an Anti-CD19 Chimeric Receptor: Assessment of the Impact of Lymphocyte Depletion Prior to T Cell Transfer
Conditions: Chronic Lymphocytic Leukemia;   Small Lymphocytic Lymphoma;   Mantle Cell Lymphoma;   Follicular Lymphoma;   Large Cell Lymphoma
Interventions: Genetic: Anti-CD19-CAR Transduced PBL;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: PG13-CD19-H3 (anti-CD19-CAR) transduced PBL)

Indicates status has not been verified in more than two years